vimarsana.com

Page 9 - ஷென்சென் காங்க்டை உயிரியல் ப்ராடக்ட்ஸ் இணை லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Fosun Pharma to buy 100 mln doses of BioNTech s COVID-19 vaccine for mainland China

 16 Dec 2020 - 14:14 A woman holds a small bottle labeled with a Coronavirus COVID-19 Vaccine sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo Reuters Shanghai Fosun Pharmaceutical Group Co Ltd on Wednesday said it will buy at least 100 million doses of a COVID-19 vaccine from Germany s BioNTech SE for use in mainland China next year, if the vaccine receives approval. The Chinese government has not announced supply deals with Western drugmakers, which instead have partnered local firms. Fosun said it will be entitled to 60% of annual gross profit from sales of doses that it will make from imported bulk ingredients, and 65% of profit from sales of doses imported ready for use.

Factbox: When and which COVID-19 vaccines are likely to be available in Asia

(Reuters) - Trial data from Pfizer Inc with partner BioNTech SE, Moderna Inc and AstraZeneca Plc has shown their experimental vaccines are effective i.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.